Review your content's performance and reach.
Become your target audience’s go-to resource for today’s hottest topics.
Understand your clients’ strategies and the most pressing issues they are facing.
Keep a step ahead of your key competitors and benchmark against them.
Questions? Please contact [email protected]
On 9 June 2022, the Health Sciences Authority (HSA) issued an advisory against the purchase and use of a topical cream for diaper rash following reports of adverse effects in an infant. The product has since been found to contain a potent steroid and a synthetic medicinal ingredient.
On 9 June 2022, the Health Sciences Authority (HSA) issued an advisory against the purchase and use of a topical cream for diaper rash following reports of adverse effects in an infant. The product was since found to contain a potent steroid and a synthetic medicinal ingredient.
Marketed on various social media platforms, product entries of the cream were accompanied by multiple customer reviews on its efficacy in relieving a variety of skin conditions. The cream also contained multiple ingredient claims viz. that it contained “all natural herb extracts” and “no steroids”. It was also advertised as being “suitable for all skin types”.
The HSA has since worked with the platform administrators to remove the affected products. Sellers have likewise been directed to immediately stop the sale of the affected products.
When determining whether health product advertisements are compliant with existing regulations, dealers should ask themselves the following:
Sellers should also ensure that all ingredients found in products are safe and in line with applicable healthcare regulations.
Content is provided for educational and informational purposes only and is not intended and should not be construed as legal advice. This may qualify as "Attorney Advertising" requiring notice in some jurisdictions. Prior results do not guarantee similar outcomes. For more information, please visit: www.bakermckenzie.com/en/client-resource-disclaimer.
If you would like to learn how Lexology can drive your content marketing strategy forward, please email [email protected] .
© Copyright 2006 - 2022 Law Business Research